Europe Veterinary Pharmaceuticals Market Size, Share, Trends, COVID-19 Impact and Growth Strategies, Segmentation 2021-2028

Spread the love

The Europe veterinary pharmaceuticals market size was valued at USD 5.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2021 to 2028. The growing awareness about zoonoses, the humanization of pets, the availability of pet insurance, and R&D initiatives by market players are the key factors anticipated to fuel the market growth in the coming years. Boehringer Ingelheim, for instance, initiated over 450 clinical studies in 2020. The company received over 240 product authorizations that included approval for Aservo Equihaler in the EU for the alleviation of severe equine asthma. The impact of the COVID-19 pandemic on the European market was varied.

Pharmaceutical drugs sold as prescription medications to treat pets may be needed for the short term or as a lifelong medication to improve the quality of life. As perAnimalhealthEurope, European households spent over EUR 2.7 billion on veterinary medicines in 2019. In order to help pet owners offset the high costs of veterinary medications and treatment, insurance companies have started offering custom or tiered pet insurance plans. Pet insurance policies provide a wide coverage including medication, tests, surgery, and diagnostics. For instance, Agria, the largest pet insurance provider in Sweden, provides coverage for several veterinary care procedures including prescription medicines as well as drugs purchased through online channels. The rising adoption of pet insurance is thus expected to fuel the market growth.

Key Player Mentioned:

 

  • MSD
  • Ceva
  • Vetoquinol S.A.
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Virbac
  • Calier

To identify the key drivers and the competitors’ insights, Request a Sample @:

https://www.grandviewresearch.com/industry-analysis/europe-veterinary-pharmaceuticals-market-report


Product Segment Analysis:

  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Others

The availability and use of generic veterinary medicines are also growing as per the European Group for Generic Veterinary Products (EGGVP). This is owing to the expiry of patents and increasing R&D activities by small, medium, and large-sized market players to leverage the opportunity and increase their market share. The formulation patent for Draxxin (a product of Zoetis) containing the active ingredient tulathromycin expired in late 2020 in Europe and other key markets.

Regional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa

Access Press Release: https://www.grandviewresearch.com/press-release/europe-veterinary-pharmaceuticals-market-analysis

However, companies also recorded increased demand for pet medications and the adoption of telehealth. Boehringer Ingelheim, for instance, experienced a rise in product sales in the companion animal segment despite restricted access to veterinary clinics due to lockdown measures. However, the company reported a drastic decline in demand for its livestock products due to the closures of slaughterhouses and restaurants. In addition, the pandemic propelled the use of online channels, thus impacting customer buying patterns and promoting curb-side or virtual vet visits.

Why Purchase this Report?

  • A strong research methodology was followed to collect data for the report. The data collected in this way are subjected to several quality checks to provide the best quality.
  • The report provides a holistic view of the competitive scenario of the Europe Veterinary Pharmaceuticals market.
  • The latest product launches, along with technological changes and developments, are included in the report.
  • The data analysis in the report will help you understand the Europe Veterinary Pharmaceuticals market dynamics projected from 2021 to 2028.
  • The Report has a vast data store, so it can accommodate your custom needs as well.

About Us:

Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world’s renowned academic  institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →